$3.443.44 +0.230.23 |(+7.177.17 %)
52W H: 43.552W L: 3.21Beta: 3.02
About Intensity Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.intensitytherapeutics.com
Frequently Asked Questions
What is the 52-week range for INTS?
The 52-week high is $43.5 and the 52-week low is $3.21.
What is the P/E ratio for INTS?
The P/E ratio data is currently unavailable.
What is the dividend yield for INTS?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -116.61%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 2.07.
Analyst Recommendation Trends
Wall Street analyst consensus for INTS over the last few months:
2026-09-01
Buy: 8
S.Buy: 2
Hold: 1
Sell: 0
2026-08-01
Buy: 8
S.Buy: 2
Hold: 1
Sell: 0
2026-07-01
Buy: 8
S.Buy: 2
Hold: 1
Sell: 0
2026-06-01
Buy: 8
S.Buy: 2
Hold: 1
Sell: 0
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-07-16 | Donovan Daniel | +5,500 | - | - |
| 2026-07-16 | Wesolowski John M | +11,000 | - | - |
| 2026-07-16 | Leahy Emer | +5,500 | - | - |
| 2026-07-16 | Talamo Joseph | +34,000 | - | - |
| 2026-07-16 | GOLDBERG MARK A | +5,500 | - | - |
| 2026-07-16 | BENDER LEWIS H | +78,000 | - | - |
| 2026-07-16 | DUBIN THOMAS I H | +5,500 | - | - |
| 2026-06-30 | Wesolowski John M | +3,688 | $3.485 | $12,853 |
| 2026-06-30 | Talamo Joseph | +1,093 | $3.485 | $3,809 |
| 2026-03-26 | BENDER LEWIS H | +37,749 | $6.11 | $230,646 |
| 2025-12-31 | Wesolowski John M | +8,918 | $0.262 | $2,337 |
| 2025-12-31 | Talamo Joseph | +14,482 | $0.262 | $3,794 |